Cetera Trust Company
GSK icon

Cetera Trust Company’s GSK GSK Stock Holding History

Cetera Trust Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$381K Hold
7,905
– – 0.19% 95
2026
Q2 		$414K Buy
7,905
+60
+0.8% +$3.17K 0.21% 90
2026
Q1 		$433K Hold
7,845
– – 0.24% 80
2025
Q4 		$385K Buy
7,845
+450
+6% +$21K 0.21% 85
2025
Q3 		$319K Buy
7,395
+400
+6% +$15.6K 0.18% 104
2025
Q2 		$269K Buy
6,995
+375
+6% +$14.3K 0.16% 126
2025
Q1 		$256K Buy
6,620
+30
+0.5% +$1.1K 0.16% 124
2024
Q4 		$223K Buy
6,590
+485
+8% +$17.5K 0.14% 156
2024
Q3 		$250K Hold
6,105
– – 0.15% 137
2024
Q2 		$235K Hold
6,105
– – 0.15% 134
2024
Q1 		$262K Sell
6,105
-160
-3% -$6.6K 0.16% 121
2023
Q4 		$232K Buy
+6,265
New +$225K 0.14% 133

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

Cetera Trust Company's GSK Position: Q3 2026 in Review

Cetera Trust Company held its GSK (GSK) position steady in Q3 2026 at 7,905 shares worth $381K. The position accounts for 0.19% of the portfolio, ranked #95.

Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 12 quarters since. The position peaked at $433K in Q1 2026. 853 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Cetera Trust Company held 7,905 shares of GSK worth $381K as of Q3 2026.
  • Cetera Trust Company left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.19% of Cetera Trust Company's portfolio in Q3 2026, its #95 holding.
  • Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 12 quarters since.
  • Cetera Trust Company's GSK position peaked at $433K in Q1 2026.
  • 853 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.